Dr. Rupesh R Kotecha, MD
Claim this profileMiami Cancer Institute
Studies Cancer
Studies Lung Cancer
23 reported clinical trials
43 drugs studied
Area of expertise
1Cancer
Stage IV
PIK3CA positive
2Lung Cancer
Stage IV
Stage III
EGFR negative
Affiliated Hospitals
Clinical Trials Rupesh R Kotecha, MD is currently running
Prophylactic Radiotherapy
for Spinal Metastases
Early palliative care has been shown to improve the quality of life and even survival for patients with metastatic cancer. More and more supportive oncology teams in cancer centers now advocate for early integration of radiation therapy (RT) in a patient's palliative management course. While multiple randomized studies have evaluated the efficacy of different RT regimens in the treatment of symptomatic bone lesions, few studies have examined the impact of early, upfront RT for asymptomatic or minimally symptomatic (non- opioid dependent) spine metastases and its efficacy in preventing skeletal-related events (SREs). Since the pathophysiology of spinal metastatic disease is distinct from other bony metastatic disease, the proposed trial seeks to understand whether it is beneficial to patients with minimally symptomatic disease to undergo upfront RT to reduce the risks of SREs and their sequelae, including hospitalizations.
Recruiting1 award Phase 1 & 2
Durvalumab + Radiation
for Lung Cancer
This trial is testing whether combining the drug durvalumab with a precise radiation treatment is more effective for early-stage lung cancer patients than using the radiation treatment alone. Durvalumab has shown promise in improving survival rates in advanced lung cancer patients and is being tested in various combinations, including with radiation therapy.
Recruiting1 award Phase 211 criteria
More about Rupesh R Kotecha, MD
Clinical Trial Related2 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Rupesh R Kotecha, MD has experience with
- Radiation Therapy
- NovoTTF-200T
- 18F Fluciclovine
- Durvalumab
- Temozolomide
- Proton Beam Radiation Therapy
Breakdown of trials Rupesh R Kotecha, MD has run
Cancer
Lung Cancer
Brain Tumor
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rupesh R Kotecha, MD specialize in?
Rupesh R Kotecha, MD focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PIK3CA positive.
Is Rupesh R Kotecha, MD currently recruiting for clinical trials?
Yes, Rupesh R Kotecha, MD is currently recruiting for 12 clinical trials in Miami Florida. If you're interested in participating, you should apply.
Are there any treatments that Rupesh R Kotecha, MD has studied deeply?
Yes, Rupesh R Kotecha, MD has studied treatments such as Radiation Therapy, NovoTTF-200T, 18F fluciclovine.
What is the best way to schedule an appointment with Rupesh R Kotecha, MD?
Apply for one of the trials that Rupesh R Kotecha, MD is conducting.
What is the office address of Rupesh R Kotecha, MD?
The office of Rupesh R Kotecha, MD is located at: Miami Cancer Institute, Miami, Florida 33176 United States. This is the address for their practice at the Miami Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.